Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...
DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $78.41 which represents a slight increase of $0.69 or 0.89% from the prior close of $77.72. The stock opened at $78.09 and touched a low ...
Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...
DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...
The American Diabetes Association has released its annual guidelines and they now include continuous glucose monitor use for non-insulin use, ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...
DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...
The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.
The global blood glucose monitoring market size was US$ 13.95 billion in 2021. The global blood glucose monitoring market is forecast to grow to US$ 27.01 billion by 2030 by registering a compound ...
Major media outlets are giving wall-to-wall coverage to UnitedHealthcare CEO Brian Thompson’s murder while taking millions in ...
In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...